The store will not work correctly when cookies are disabled.
N-(2-chloro-5-propionamidophenyl)benzo[d][1,3]dioxole-5-carboxamide
ID: ALA4514029
PubChem CID: 969063
Max Phase: Preclinical
Molecular Formula: C17H15ClN2O4
Molecular Weight: 346.77
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCC(=O)Nc1ccc(Cl)c(NC(=O)c2ccc3c(c2)OCO3)c1
Standard InChI: InChI=1S/C17H15ClN2O4/c1-2-16(21)19-11-4-5-12(18)13(8-11)20-17(22)10-3-6-14-15(7-10)24-9-23-14/h3-8H,2,9H2,1H3,(H,19,21)(H,20,22)
Standard InChI Key: YSQOPHSKDNWFIP-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
8.8432 -16.6575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2598 -17.4765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2570 -16.6539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5483 -16.2486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5459 -15.4314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2524 -15.0207 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8370 -15.0249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2500 -14.2035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9583 -13.7973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9562 -12.9809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2467 -12.5736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5379 -12.9887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5435 -13.8037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5501 -17.8860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8424 -17.4800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2376 -18.0277 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5716 -18.7722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3827 -18.6845 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8390 -14.2178 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.6629 -12.5705 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6608 -11.7533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3675 -11.3429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9521 -11.3465 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0762 -11.7498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 15 2 0
14 2 2 0
2 3 1 0
3 4 2 0
4 1 1 0
4 5 1 0
5 6 1 0
5 7 2 0
6 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
13 19 1 0
10 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
22 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.77 | Molecular Weight (Monoisotopic): 346.0720 | AlogP: 3.67 | #Rotatable Bonds: 4 |
Polar Surface Area: 76.66 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.73 | CX Basic pKa: ┄ | CX LogP: 3.23 | CX LogD: 3.23 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.89 | Np Likeness Score: -1.69 |
References
1. Astolfi A, Kudolo M, Brea J, Manni G, Manfroni G, Palazzotti D, Sabatini S, Cecchetti F, Felicetti T, Cannalire R, Massari S, Tabarrini O, Loza MI, Fallarino F, Cecchetti V, Laufer SA, Barreca ML.. (2019) Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation., 182 [PMID:31445234] [10.1016/j.ejmech.2019.111624] |